Symposium: Future of Biologic Drug Discovery and Development
Free to attend, lunch and light dinner will be provided. Join Biocytogen to learn more about the cutting-edge technologies and latest research in biologic drug. The symposium is co-organized by Biocytogen and AcroBiosystem, focusing mainly on therapeutic antibody and biologic drug discovery and development. Theme: Future of Biologic Drug Discovery and Development Time: June 13th, 1:00 PM […]
Biocytogen’s President & CEO, Dr. Yuelei Shen, Speaks at Harvard China Forum at Harvard University
April 15, 2019
Harvard College China Forum, an annual Harvard tradition for 22 years, welcomed and opened to 1,200 domestic and international participants and over 100 domestic and international speakers in Cambridge, Massachusetts, USA, on April 12-14, 2019. Biocytogen’s President & CEO, Dr. Yuelei Shen, WuXi AppTec’s US CEO, Dr. Richard Connell, and BlackRock’s healthscience fund manager, Dr. Erin (Hongying) […]
Biocytogen’s Integrated One-stop Preclinical Services and the RenMab Mouse Shine at AACR 2019
April 7, 2019
American Association for Cancer Research (AACR) Annual Meeting 2019 was held in Atlanta, Georgia from March 29 to April 3, 2019, with a theme of “Integrative Cancer Science, Global Impact, Individualized Patient Care.” As one of the largest and most prominent global oncology research conferences, this meeting attracted basic science and clinical researchers from leading academic […]
Former Swedish Prime Minister Visits Biocytogen
January 29, 2019
Former Swedish Prime Minister, former president of the European Council Mr. Fredrik Reinfeldt and Executive Chairman of Nordic Growth Technology (NGT) Partners, professor Niclas Adler visited Biocytogen on January 23, 2019. This visit was accompanied by Dr. Zhi Yang, founding Partner of BioVeda China Fund. Biocytogen’s CEO Dr. Yuelei Shen, CSO Dr. Yi Yang, and […]
Biocytogen at the at the European Society for Medical Oncology (ESMO) 2018 annual meeting
Biocytogen is excited to exhibit at the European Society for Medical Oncology (ESMO) 2018 annual meeting, which will take place in Munich, Germany from between 19-23 October 2018! With this year’s theme “Securing access to optimal cancer care” and sessions focusing on immunotherapy, precision medicine, big data in cancer management, this meeting will attract clinicians, researchers, […]
Biocytogen seminar at University of Toronto
Dr. James Jin, the Vice President of Biocytogen, will hold a seminar at the University of Toronto. This seminar mainly focuses on CRISPR/Cas9 based Extreme Genome Editing (EGE) Technology developed by Biocytogen and its Applications. The seminar is hosted by Dr. Tianru Jin from the University of Toronto Department of Physiology. Welcome to the seminar! […]
Biocytogen Seminar at University of Michigan
Dr. James Jin, the Vice President of Biocytogen, will hold a seminar at the University of Michigan. This seminar mainly focuses on CRISPR/Cas9 based Extreme Genome Editing (EGE) Technology developed by Biocytogen and its Applications. The seminar is hosted by Dr. Qiao Li at the University of Michigan Department of Surgery. Welcome to the seminar! […]
Immuno-Oncology Summit
About the Immuno-Oncology Summit Biocytogen Boston Corporation will be exhibiting at the 2018 Immuno-Oncology Summit in Boston, MA, Aug 27-31. The Immuno-Oncology Summit brings together a unique and international mix of large and medium pharmaceutical and biotech companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Summit a perfect meeting place […]
Biocytogen showcases innovative gene-editing strategies at Experimental Biolo
May 2, 2018
BiocytogenTM Gene Targeting Services participated at the Experimental Biology (EB) 2018 meeting in San Diego, CA, April 22-24. This conference was comprised of more than 14,000 attendees from academic, industry and government sectors, and covered topics and advances in anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. We were excited to learn about […]
